Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke.
about
Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactionsPharmacological disruption of insulin-like growth factor 1 binding to IGF-binding proteins restores anabolic responses in human osteoarthritic chondrocytesThe interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrationsMechanisms of tumor necrosis factor alpha action on neurodegeneration: interaction with insulin-like growth factor-1Neuroprotection in cerebrovascular disease.What's new in the IGF-binding proteins?The emerging role of IGF-1 deficiency in cardiovascular aging: recent advancesInsulin-like growth factor I and Alzheimer's disease: therapeutic prospects?RETRACTED: A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptideThe insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV)Insulin growth factor-1 gene transfer enhances neurovascular remodeling and improves long-term stroke outcome in mice.Insulin-like growth factor-1 in CNS and cerebrovascular agingLocal insulin-like growth factor I prevents sepsis-induced muscle atrophy.Trophic factors and cell therapy to stimulate brain repair after ischaemic stroke.Humanin: Functional Interfaces with IGF-I.Identification of a nonpeptide ligand that releases bioactive insulin-like growth factor-I from its binding protein complex.Postischemic IGF-1 gene transfer promotes neurovascular regeneration after experimental stroke.Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture.Neuroprotective effects of insulin-like growth factor-binding protein ligand inhibitors in vitro and in vivo.Enhanced production and proteolytic degradation of insulin-like growth factor binding protein-2 in proliferating rat astrocytes.Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB.NMDA receptor mediated changes in IGF-II gene expression in the rat brain after injury and the possible role of nitric oxide.Neurite Growth and Polarization on Vitronectin Substrate after in Vitro Trauma is not Enhanced after IGF Treatment
P2860
Q24533385-FD86DF09-54F7-437E-A1D2-C98F2FCF1961Q24796505-6F31EF3A-D62C-46B7-BC85-8E3EEA8B8B86Q27633115-73ACE20F-AA4D-464E-8875-81F78E7962BBQ30447872-A475299C-9B96-4555-A214-608865EB74E2Q33712785-4ABC90FD-403F-481E-A273-3958D0EF5C01Q34074787-1FB8B51D-EDED-491B-8614-95903C7816B5Q35874076-B73F490C-E0CC-4874-9E52-0F935DE456B9Q35947431-D5A23F1E-240A-4BD8-9D2A-37F164EA9022Q36107258-7C558716-CD79-4CD4-8A37-194D579333CBQ36438395-A110CCF9-4D0D-4C9E-8BFE-4A51ED49EBF3Q36468522-BCFF1FF2-79B6-4DF4-8A80-A25F4BD9FAF5Q36736740-A6E88DBD-CF14-47D2-9F7C-8C7B50CA5B2AQ36909687-A8E1AFA4-BF54-4E59-BECB-2B68E262B7A2Q36973428-82F66FE1-B4E7-41E9-86D3-7CECFA812DD4Q37381871-88A43657-5672-4E70-9605-49EF7EEB97A0Q37997539-78C195E2-95E2-44F1-8AEE-3350A96DE08AQ38809118-BDB1164B-86E4-42F7-8E95-BA3F8358A22AQ40793635-3341DDCD-D8BE-44E7-B95F-83F8F6936895Q41771794-BA9485E7-F3D0-4323-8F34-91CBF714E0E4Q42162185-BD3FAEBD-F864-464C-9733-815E3ABAF029Q44361130-02A5BF86-F27C-4CD5-B915-CFEEED01B29EQ44973927-49F5B656-5326-4341-B81B-9F35B34651CBQ48254872-AFE4AD08-13AD-4202-9525-2BD052C70F56Q49142301-B74EE4AC-A6EE-4D4F-9C70-999B5091A9E2Q58788300-F8A018F8-CA63-4906-8903-4BC3E831C130
P2860
Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Displacement of insulin-like g ...... otential treatment for stroke.
@ast
Displacement of insulin-like g ...... otential treatment for stroke.
@en
type
label
Displacement of insulin-like g ...... otential treatment for stroke.
@ast
Displacement of insulin-like g ...... otential treatment for stroke.
@en
prefLabel
Displacement of insulin-like g ...... otential treatment for stroke.
@ast
Displacement of insulin-like g ...... otential treatment for stroke.
@en
P2093
P2860
P356
P1476
Displacement of insulin-like g ...... otential treatment for stroke.
@en
P2093
A C Foster
D C Chalmers
E B De Souza
S A Loddick
P2860
P304
P356
10.1073/PNAS.95.4.1894
P407
P577
1998-02-01T00:00:00Z